Application

17264373 · PROLONGED ADMINISTRATION OF A BISPECIFIC ANTIBODY CONSTRUCT BINDING TO CD33 AND CD3

Filed 2021-01-29 · Abandoned The official file ↗ · Art unit 1647 · Examiner Pratik Thapa · CPC C07K 16/2803 · AMGEN INC. · Marshall, Gerstein & Borun LLP (Amgen)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

35.1 mo

to disposition 42.3 mo

Statutes raised

103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.